Total Funding
51
6
Total FundingSeries C raised
Growth Score
-5 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
22688
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
- Tao Fu: Chief Executive Officer and FounderPast Role: Zai Lab, President, COO & Director
About the Company
Attovia develops biotherapeutics aimed at treating immune-mediated diseases through its proprietary ATTOBODY technology. The company focuses on creating innovative therapies that target various immune responses, contributing to advancements in the biotechnology sector. Attovia is actively engaged in research and development, working on a pipeline
of therapeutics designed to address unmet medical needs in immune disorders and oncology. Recent funding efforts support the progression of its clinical programs, highlighting its commitment to advancing healthcare solutions. By leveraging its unique technology, Attovia seeks to enhance treatment options for patients suffering from complex diseases.
